John L. Higgins
2014
In 2014, John L. Higgins earned a total compensation of $6M as Chief Executive Officer at Ligand Pharmaceuticals, a 101% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $383,097 |
---|---|
Option Awards | $4,552,951 |
Salary | $510,198 |
Stock Awards | $595,360 |
Other | $5,650 |
Total | $6,047,256 |
Higgins received $4.6M in option awards, accounting for 75% of the total pay in 2014.
Higgins also received $383.1K in non-equity incentive plan, $510.2K in salary, $595.4K in stock awards and $5.7K in other compensation.
Rankings
In 2014, John L. Higgins' compensation ranked 1,189th out of 13,032 executives tracked by ExecPay. In other words, Higgins earned more than 90.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,189 | 91st |
Manufacturing | 438 | 91st |
Chemicals And Allied Products | 142 | 92nd |
Drugs | 112 | 92nd |
Pharmaceutical Preparations | 100 | 90th |
Higgins' colleagues
We found four more compensation records of executives who worked with John L. Higgins at Ligand Pharmaceuticals in 2014.